ClinicalTrials.gov URL
Acknowledgement
5 Business Days
DigmBio, Inc
EA Policies for Single Patient
Digmbio does not currently offer single-patient expanded access to DM5167. DM5167 is an investigational product and is currently being evaluated in clinical trials. Digmbio believes that access to DM5167 should currently be limited to controlled clinical trials while its safety and efficacy are being evaluated. This policy may be revised as the DM5167 development program progresses and additional clinical data become available.